Device
BIFOCAL IOL
BIFOCAL IOL is a medical device with 2 clinical trials. Historical success rate of 100.0%.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown150%
completed150%
Recent Activity
0 active trials
Showing 2 of 2
completednot_applicable
The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL
NCT07008768
unknown
Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia
NCT04265846
Clinical Trials (2)
Showing 2 of 2 trials
NCT07008768Not Applicable
The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL
NCT04265846
Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2